#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Blastic plasmacytoid dendritic cell neoplasia Follicular lymphoma stage II Frostbite Retinitis pigmentosa Rosai-Dorfman syndrome Friedreich's ataxia Rheumatoid arthritis Leukoencephalopathy Rhabdoid tumour T-cell type acute leukaemia Neuropathic arthropathy Acute lymphocytic leukaemia Li-Fraumeni syndrome Cryoglobulinaemia More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Life with Disease Alexander disease Phenylketonuria – Basic Information Pulmonary sarcoidosis – Diagnostics Haemophilia B without inhibitors – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Myelodysplastic syndrome – Treatment Erdheim-Chester disease – Trials in Disease Amyotrophic lateral sclerosis – Life with Disease Stevens-Johnson syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betaine Citrate Tebipenem Pivoxil Hydrobromide Lenacapavir Sodium Mk-1200 Emiplacel Procarbazine Hydrochloride Namodenoson LUMC-BOB1-B7-TCR.1 Eplerenone D-Biotin Berubicin Hydrochloride Inupadenant Necvax-Neo1 Metronidazole Bio89-100 Bay 3283142 Tapderimotide Evg321 Hydroxocobalamin SARACATINIB More therapies…

    Learn about Your Condition

    Sarcoma metastatic Cutaneous sarcoidosis Short stature Pigmentary glaucoma Ovarian epithelial cancer Vascular malformation Propionic acidaemia Inflammation Stevens-Johnson syndrome Colon cancer stage II Crigler-Najjar syndrome Follicular lymphoma stage II Complicated appendicitis Hodgkin's disease Insomnia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU de Liege

CHU de Liege

Domaine Universitaire du Sart-Tilman B35, Liege, 4000, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study of iodofalan (131I) and lomustine combination therapy compared to lomustine alone in patients with first recurrent glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • 4-IODOPHENYLALANINE I-131
    • Lomustine
    Austria Belgium Denmark France Germany The Netherlands +1

  • Study of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium The Netherlands

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Erythromycin Lactobionate
    • Oseltamivir
    • Roxithromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!